![2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-diyl diacetate](https://static.cymitquimica.com/cas-image/323373-2-methyl-3-2e-7r-11r-371115-tetramethylhexadec-2-en-1-yl-naphthalene-14-diyl-diacetate.png)
CAS: 604-87-5 - 2-methyl-3-[(2E,7R,11R)-3,7,11,15-tetramethylhexadec-2-en-1-yl]naphthalene-1,4-diyl diacetate
Fórmula:C35H52O4
InChI:InChI=1/C35H52O4/c1-24(2)14-11-15-25(3)16-12-17-26(4)18-13-19-27(5)22-23-31-28(6)34(38-29(7)36)32-20-9-10-21-33(32)35(31)39-30(8)37/h9-10,20-22,24-26H,11-19,23H2,1-8H3/b27-22+/t25-,26-/m1/s1
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Dihydro Vitamin K1 Diacetate (Di-O-Acetyl-Dihydrophyllochinon) REF: 4Z-V-1416CAS: 604-87-5 | - - - | A consultar | Vie 13 Dic 24 |
 | Dihydrovitamin K1 Diacetate REF: TR-D448498CAS: 604-87-5 | - - - | 183,00 €~1.792,00 € | Lun 16 Dic 24 |
 | Dihydrovitamin K1 diacetate REF: 3D-AAA60487CAS: 604-87-5 | Min. 95% | A consultar | Vie 17 Ene 25 |
Dihydro Vitamin K1 Diacetate (Di-O-Acetyl-Dihydrophyllochinon)
CAS:604-87-5
Fórmula:
C35H52O4
Peso molecular:
536.80
Ref: 4Z-V-1416
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 13 de Diciembre de 2024
Dihydrovitamin K1 Diacetate
Producto controladoCAS:604-87-5
Applications Dihydrovitamin K1 Diacetate is an impurity of Vitamin K1 (V676080), which occurs widely in …
Fórmula:
C35H52O4
Forma y color:
Colourless
Peso molecular:
536.78
Ref: TR-D448498
| 5mg | 183,00 € | ||
| 25mg | 692,00 € | ||
| 100mg | 1.792,00 € |
Entrega estimada en Estados Unidos, el Lunes 16 de Diciembre de 2024
Dihydrovitamin K1 diacetate
CAS:604-87-5
Dihydrovitamin K1 diacetate is a medicinal compound with potent anticancer properties. It has been shown …
Fórmula:
C35H52O4
Pureza:
Min. 95%
Peso molecular:
536.8 g/mol
Ref: 3D-AAA60487
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 17 de Enero de 2025
